Azilsartan Tablets Special Drug Use Surveillance: Long-term Use
Phase of Trial: Phase IV
Latest Information Update: 23 Jan 2019
Price : $35 *
At a glance
- Drugs Azilsartan (Primary)
- Indications Hypertension
- Focus Adverse reactions
- Sponsors Takeda
- 22 Apr 2016 Status changed from active, no longer recruiting to completed.
- 14 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 26 Mar 2014 New trial record